Rickettsia australis Activates Inflammasome in Human and Murine Macrophages

Claire Smalley1, Jeremy Bechelli1, Dedeke Rockx-Brouwer1

  • 1Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, Texas, United States of America.

Plos One
|July 1, 2016
PubMed

Insights

Rickettsia australis infection activates the inflammasome pathway in macrophages, involving ASC and NLRP3, to control bacterial levels. This immune response is crucial for host defense against this pathogen.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Rickettsiae are intracellular bacteria that escape host cell vacuoles.
  • Inflammasomes are critical immune sensors that detect invading pathogens.

Purpose of the Study:

  • To investigate the interaction between Rickettsia australis and inflammasome activation in macrophages.
  • To determine the role of specific inflammasome components (caspase-1, ASC, NLRP3) in the host response to R. australis.

Main Methods:

  • In vitro infection of human and mouse macrophages with R. australis.
  • Measurement of IL-1β and IL-18 secretion.
  • Use of inflammasome component-deficient macrophages (caspase-1/11-/-, ASC-/-, NLRP3-/-) and wild-type controls.
  • Assessment of bacterial load in infected mice.

Main Results:

  • R. australis induced IL-1β secretion in human macrophages dependent on caspase-1.
  • Infection of mouse macrophages led to dose-dependent secretion of IL-1β and IL-18, involving ASC and caspase-1.
  • NLRP3 inflammasome contributed to R. australis recognition in vitro.
  • NLRP3 deficiency led to increased rickettsial load in the spleen of infected mice, indicating a tissue-specific role.

Conclusions:

  • Rickettsia australis activates the ASC-dependent inflammasome in macrophages.
  • The NLRP3 inflammasome plays a role in controlling R. australis infection in a tissue-specific manner in vivo.
  • This study elucidates the inflammasome-mediated immune response to R. australis.